Oppenheimer Asset Management on Monday raised its year-end target for the S&P 500 index to 7,100, the highest among major ...

Trump's trade deals with the EU and Japan pave the way for the stock market to end with it's third straight annual gain of ...

Just a few years before 2023’s Barbenheimer phenomenon, Margot Robbie starred in a complex biopic that was much Oppenheimer ...

Analysts upgraded Carvana shares, arguing the company is a "digitally-driven disruptor" in the fractured used car market.

Oppenheimer initiated coverage of the buy now, pay later firm Monday, issuing an "outperform" rating for Affirm stock.

Carvana Co. (NYSE:CVNA) is one of the best multibagger stocks according to hedge funds. On July 25, 2025, Oppenheimer analyst ...

Sarepta Therapeutics ( NASDAQ: SRPT) was upgraded to Neutral from Underweight at J.P. Morgan as it sees FDA's Elevidys hold removal recommendation in ambulatory patients as a clear win.

Visa and Mastercard are expected to report higher quarterly profits this week on steady consumer spending, and analysts will ...

Brad Pitt's sports drama F1 has been storming the box office ever since it hit the cinemas. The Joseph Kosinski-directed ...

Rory McIlroy isn’t spending the night before The Open’s final round at the practice range or obsessing over stats. Instead, ...

The gaming platform's algorithm may help it identify popular concepts before competitors, as it did with 'Grow A Garden,' analysts said.

Visa and Mastercard are expected to report higher quarterly profits this week on steady consumer spending, and analysts will ...